Clinical evidence from the SURMOUNT-4 randomized withdrawal study indicates that patients typically regain a substantial portion of lost weight after discontinuation
judge refused to let compounding pharmacies continue making copies of Eli Lilly's diabetes drugs, including its tirzepatide brands, Zepbound and Mounjaro
In clinical trials, participants saw significant reductions in body weight
NCT06534411 Disclaimer: This article is for informational and educational purposes only
International Journal of Obesity GLP-1 agonists, body composition, and visceral adipose tissue meta-analysis, April 2026
Please see Medication Guide and Prescribing Information, including Boxed Warning, for Wegovy at About the Wegovy savings offer The Wegovy savings offer gives cash-paying patients or those with commercial insurance that does not cover obesity medicines access to a 28-day supply (one box) of Wegovy for $499